JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2023  1,500
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 58(2024) N 6 p. 1312-1320; DOI 10.1134/S0026893324060098 Full Text

J.V. Popova1,2 (ORCID:0000-0001-8800-8645), V.D. Bets3 (ORCID:0000-0002-5148-9067), E.S. Omelina1 (ORCID:0000-0002-2189-5101), L.V. Boldyreva1,4 (ORCID:/0000-0003-0716-4545), E.N. Kozhevnikova1,2* (orcid:0000-0003-3210-3322)

Adapting Mouse Genome Editing Technique from Scratch Using in utero Electroporation

1Institute of Molecular and Cellular Biology, Siberian Branch, Russian Academy of Sciences, Novosibirsk, 630090 Russia
2Novosibirsk State Agrarian University, Novosibirsk, 630039 Russia
3Novosibirsk State Technical University, Novosibirsk, 630073 Russia
4Scientific Research Institute of Neurosciences and Medicine, Novosibirsk, 630117 Russia


*kozhevnikova@mcb.nsc.ru
Received - 2024-04-12; Revised - 2024-07-08; Accepted - 2024-07-25

Mouse genome modification requires costly equipment and highly skilled personnel to manipulate zygotes. A number of zygote electroporation techniques were reported to be highly efficient in gene delivery. One of these methods called i-GONAD (improved Genome-editing via Oviductal Nucleic Acids Delivery) describes electroporation-based gene transfer to zygotes in utero. Here we adopted this technology to develop an easy-to-use and cost-effective pipeline enabling mouse genome-editing from scratch with minimal requirements to operator skills and animal use. We chose the CRISPR/Cas9 system as a genome editing tool and i-GONAD as a gene delivery method to produce Il10 knockout in C57BL/6 mice. Three animals out of 13 delivered pups (23%) were genetically compromised at Il10 locus suggesting the feasibility of the approach. This protocol provides detailed description of the used technical settings paired with troubleshooting tips and could be of interest to those who aim at establishing in-house mouse transgenesis pipeline at minimal equipment cost from scratch.

i-GONAD, genome editing, CRISPR/Cas9, in utero, mouse, transgenic laboratory



JMB-FOOTER RAS-JOURNALS